slide 1

Back to the List of the Granted Patents                                                Click here to download AP2616 PDF

(11)    Patent No :    AP 2616   
(21)    Application No :    AP/P/2007/004093   
(22)    Filing Date :    21.09.2005   
(24)    Date of Grant &    18.03.2013   
           
(45)    Publication :

(30)  Priority Data       
(33) Country    (31) Number    (32) Date
AU    2005900134    13.01.2005
(84)    Designated State

BW    GM    GH    KE    LS    MW  MZ   NA   SL
SD    SZ    T Z    UG    ZM    ZW

(73) Applicant(s)

UNIVERSITY OF WOLLONGONG, Northfields Avenue,

Wollongong, 2522, New South Wales,
Australia
(72) Inventors

BOYLE Timothy Patrick, Australia

BREMNER John Barnard, Australia

BRKIC Zinka, Australia

et al

(74) Representative

FISHER CORMACK & BOTHA
(51)    International  Classification   C07C 277/00 (2006.01)    C07C 279/04 (2006.01)
    C07C 279/24 (2006.01)    CO7C 231/02 (2006.01)
    C07C 269/06 (2006.01)    C07C 271/00 (2006.01)
    C07C 233/64 (2006.01)    C07C 233/48 (2006.01)
    C07C 233/54 (2006.01)    C07C 235/26 (2006.01)
    C07D 273/08 (2006.01)    A61P 31/04 (2006.01)
    C07C 235/30 (2006.01)    C07C 233/78 (2006.01)
    C07C 233/49 (2006.01)    C07C 233/47 (2006.01)
    C07C 235/34 (2006.01)    C07D 263/32 (2006.01)
    C07D 263/46 (2006.01)    C07D 213/46 (2006.01)
    C07D 273/02 (2006.01)    C07D 311/70 (2006.01)
    A61K 31/353 (2006.01)    A61K 31/216 (2006.01)
(54)    Title   
    Peptidic compounds   

(57)    Abstract
The present invention provides a compound of formula I, II, III and IV as defined herein and pharmaceutically acceptable derivatives thereof. The present invention further provides use of the compounds of the present invention in the treatment of bacterial infection and in the treatment of HIV infection. Also provided are pharmaceutical compositions comprising the compounds of the present invention.
(56)    Documents Cited :    BREMNER J B et al:    WO 03/002545 A

Newsletter

Join our newsletter for CIPIT news through subscriptions!

SEND

Social Media

    

Contact Us

TEL : (254) 703 034 612